Drugstores make slow headway on staffing problems
Joan Cohrs missed her chance to grab a prescription at her usual drugstore by about…
Author: STAT
‘It’s taken longer than I thought’: A former FDA commissioner on the loosened restrictions on abortion pills
When the Food and Drug Administration lifted some — but not all — of its…
STAT+: The FDA has approved a new Alzheimer’s drug, but wide access may depend on CMS easing restrictions
Now that the U.S. Food and Drug Administration has granted accelerated approval to the widely…
Officials in Nebraska, South Dakota, Oklahoma begin to probe prisons’ hepatitis C treatment efforts
WASHINGTON — Members of Congress, state legislators, regulators, and legal advocates are calling on prisons…
FDA approves Alzheimer’s drug shown to moderately slow cognitive decline in early stages of the disease
The Food and Drug Administration on Friday approved a new Alzheimer’s disease treatment that moderately…
As respiratory diseases rise, EPA tightens air quality standards
The Environmental Protection Agency announced on Friday more aggressive air quality standards for particulate matter,…
STAT+: Pharmalittle: Pfizer scaling back early-stage research into rare diseases; BioNTech and U.K. partner on cancer trials
And so, another working week will soon draw to a close. Not a moment too…
Opinion: STAT+: Continuous manufacturing can help pharma companies save time, money, and more
The pharmaceutical industry has been slow to adopt a business practice that is faster, safer,…
A year after a nurse’s loss to suicide, his friends are building out a peer support network
When Michael Odell, an intensive care nurse, died by suicide a year ago this month,…
STAT+: Fate Therapeutics plans mass layoffs, after early end to cell therapy deal with Janssen
SAN DIEGO — Fate Therapeutics, a biotech upstart with big ambitions to use cell-based therapies…
STAT+: Pharma’s ambitious antibiotic venture fund makes another investment
For only the second time since launching nearly two years ago, the AMR Action Fund…
Listen: #JPM23, the future of Alzheimer’s, & rising Covid variants
What does 2023 have in store for biotech? How can the FDA win back trust?…
.jpg)
STAT+: Pharmalittle: New report gives glimpse into safety of an Alzheimer’s drug; Walgreens looks to dispense an abortion pill
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Biogen shakes up R&D chief role, makes Singhal permanent replacement
More than a year after Al Sandrock was pushed out as Biogen’s R&D chief, the…
Opinion: Health record interoperability needs to include dental health records
As 2023 begins, health care providers in the United States must make health records more…
STAT+: 3 drug pricing issues to watch in 2023
WASHINGTON — The legislative saga on drug pricing is mostly over for now, but drug…
STAT+: ‘Stuck in a rut’: As debate flares over access to medicines, the future of voluntary licensing is up in the air
ANNECY, FRANCE — At first blush, the deal was hailed as a breakthrough. Last fall,…
Walgreens to pursue certification to provide abortion pills in pharmacies
Walgreens plans to seek certification to begin providing abortion pills under new Food and Drug…
STAT+: As FDA considers new Alzheimer’s drug, a case study details safety concerns
Investigators on Wednesday released the first detailed case report about a patient who died after…
Senior WHO official faults China for undercounting Covid deaths
China is underreporting deaths from Covid-19, a senior official of the World Health Organization said…
California’s dark history of forced sterilizations comes into focus as it seeks victims to pay reparations
SACRAMENTO, Calif. (AP) — About 600 people alive today can’t have children because California’s government…
STAT+: Pharmalittle: FDA rule change allows pharmacies to offer abortion pills; Medicare could have saved billions if inflationary rebate law existed
Top of the morning to you, and a fine one it is. Balmy breezes and…
STAT+: Roivant-Pfizer inflammatory bowel drug hits high expectations in mid-stage study
An experimental inflammatory bowel disease medicine that serves as the basis for a partnership between…
STAT+: Geron, biotech that once sparked talk of immortality, finally gets a (more modest) success
Geron Corporation, a biotech that made sci-fi-sounding headlines through the 90s and 2000s before shuffling…
Opinion: Emergency Medical Treatment and Labor Act is no end-run around abortion bans
The emergency department is often called a hospital’s front door. For many people desperate for…
.jpg)
3 challenges to watch in global health in 2023
For the first two years of the Covid-19 pandemic, people working in the infectious diseases…
STAT+: The health tech tracker for 2023’s first quarter: 12 industry events to watch
Continuing economic uncertainty and the threat of a recession are casting a pall over health…
For people with disabilities, reproductive health care comes with deep-rooted barriers
Pregnancy, for the average person, is an exercise of extremes — swelling body, welling emotions,…
FDA finalizes rule expanding availability of abortion pills
WASHINGTON (AP) — The Food and Drug Administration on Tuesday finalized a rule change that…
STAT+: Medicare would have saved $3.7 billion on Part B drugs if inflationary rebates were around in a recent three-year period
If rebates had been required for price hikes on most of the nearly 100 medicines…
Beijing rebukes new Covid testing requirements for travelers from China
BEIJING — The Chinese government sharply criticized COVID-19 testing requirements imposed on passengers from China…
Opinion: NIH advances landmark recommendations on disability inclusion and anti-ableism
A diverse and inclusive workforce benefits science and research. But unless it includes people living…
STAT+: Pharmalittle: Pharma plans to raise U.S. drug prices in January; U.S. sues AmerisourceBergen over opioid crisis
Good morning, everyone, and welcome to a new year. We hope the holiday respite was…
Paying research participants — a lot — may be a key to increasing diversity in studies
Paying people to participate in medical research has been proposed as a way to narrow…
Covid’s winter surge is poised to exceed summer peak
The number of people in the United States hospitalized with Covid-19 is about to surpass…
Opinion: Better information on sexual orientation and gender identity is needed to improve LGBTQ+ health
Over the past three years, many Americans learned more about epidemiology than they ever knew…
Priorities pile up for HHS, FDA, CMS, NIH, and other health agencies
WASHINGTON — The nation’s health agencies already have a long to-do list for 2023. Top…
STAT+: 3 trends to watch in hospitals and health insurance in 2023
For almost three years, hospitals and health insurers have been riding the waves of the…
Opinion: The Aduhelm Operetta: ‘I’ve got a little list’
The Congressional report on the FDA’s approval of Aduhelm makes some good points. As regulatory…
Diabetes in youth is set to skyrocket in coming decades
The number of young people in the U.S. with type 2 diabetes could surge by…
We wish we’d written that: STAT staffers share their favorite stories of 2022
This year, STAT deepened its footholds in a number of coverage areas, from hospitals and…
Wegovy may help obese teens lose weight but isn’t a magic bullet
The Food and Drug Administration’s approval of Wegovy, Novo Nordisk’s latest obesity drug, for adolescents…
Watch: A wave of overdoses is hitting an already vulnerable population
Francesca Coleman, known to friends as “St. Louis,” has been unhoused since the age of…
STAT+: Providers seeking resolution of billing disputes under the No Surprises Act cause a major backlog of cases
Health care providers are swamping the government with billing disputes under the new law that…
A letter from the executive editor: The Aduhelm Files
Dear Reader, From STAT’s first investigations in June 2021 revealing why the FDA gave the…
FDA, Biogen, and an Alzheimer’s drug approval: 8 key takeaways from congressional investigation
Congressional investigators sorted through more than 500,000 pages of documents from the Food and Drug…
STAT+: ‘Rife with irregularities’: Congressional investigation reveals FDA’s approval of Aduhelm marked by secret discussions, breaches of protocol
WASHINGTON — The Food and Drug Administration’s review and approval of a controversial Alzheimer’s drug…
STAT+: Pfizer says hemophilia B gene therapy significantly reduces bleeds
Pfizer said Thursday that its experimental gene therapy for hemophilia B significantly reduced the number…
Watch: The ‘fourth wave’ of the overdose crisis
For over two decades, a crisis of opioid overdoses has been one of the most…
3 things to watch in chronic disease in 2023: obesity drugs, long Covid and health care costs
The very term “chronic disease” might imply that little changes — or improves — over…